Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP is serving as legal counsel to Neurogene Inc. and Fenwick & West LLP is serving as legal counsel to Neoleukin Therapeutics,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Day One Biopharmaceuticals, Inc. on the offering, while Cooley LLP represented the underwriters. Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company focused...
You must be a Standard 1 Year member to access this content.
Fenwick represented Morphic Holding, Inc. on the deal. Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment...
You must be a Standard 1 Year member to access this content.
Fenwick advised DexCom on the offering, while Davis Polk advised the representatives of the initial purchasers and the counterparties to the capped call transactions. DexCom, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering while Fenwick represented Workday. Workday, Inc. executed an $3 billion SEC-registered debt offering. The offering consisted of $1...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised VELO3D Inc. on the deal. VELO3D Inc., a leader in additive manufacturing for high-value metal parts, announced its definitive business combination...
You must be a Standard 1 Year member to access this content.
